Skip to content

Smoking Cessation in the Surgical Pathway Before Major Lung Surgery

A Trial to Study the Effectiveness of Smoking Cessation in the Surgical Pathway Before Major Lung Surgery: Project MURRAY Feasibility Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04190966
Acronym
MURRAY
Enrollment
120
Registered
2019-12-09
Start date
2020-01-31
Completion date
2021-12-31
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation, Thoracic Surgery

Keywords

Postoperative Pulmonary Complications, Smoking Cessation Intervention

Brief summary

This is a feasibility study of a personalised, integrated smoking cessation in the surgical pathway in patients undergoing major elective thoracic surgery when compared to usual care of standard community/hospital based NHS smoking cessation. Half the patients will receive the intervention and half the patients will receive usual care.

Detailed description

Smoking prior to major thoracic surgery is a major risk factor for development of postoperative complications which effect both short and long-term outcome. Despite this 1 in 5 patients continue to smoke before their operation. Project MURRAY is a trial comparing the effectiveness of personalised integrated smoking cessation delivered by trained health-care practitioners in the thoracic surgical pathway, and is a three part package of behaviour interventions and pharmacotherapy as per National Institute of Clinical Excellence (NICE)/ National Centre for Smoking Cessation Training (NCSCT) guidance which is supported by an adjunct web-based application. This is a pilot study to evaluate feasibility of a substantive trial and study processes in 5 adult thoracic centres including the trial coordinating site at the University Hospitals Birmingham NHS Foundation Trust. This is a multicentre feasibility study, with aim for equal weighting between the two arms of the integrated smoking cessation and an observation only group of usual care.

Interventions

BEHAVIORALIntegrated Behavioural therapy

Integrated smoking cessation behavioural therapy

DRUGIntegrated Pharmacotherapy

Integrated smoking cessation pharmacotherapy including choice of combination nicotine replacement therapy, varenicline or electronic cigarettes

DEVICEIntegrated Web-based application

Integrated smoking cessation web-based application

Sponsors

University College, London
CollaboratorOTHER
University of Birmingham
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Current tobacco smoker (smoked within the last 28 days) * Major Thoracic Surgery (including both open and minimally invasive approach) * Able to provide written informed consent * At least 1 weeks' time to surgery * Age over 18 years

Exclusion criteria

* Emergency thoracic surgery * Inability to perform exhaled carbon monoxide (CO) measurements

Design outcomes

Primary

MeasureTime frameDescription
Recruitment0 days from recruitmentTo establish the number of patients who agree to participate in the intervention as a proportion of those eligible to enter the study

Secondary

MeasureTime frameDescription
Variability of smoking cessation practices0 days from recruitment, 1 day of surgery, 1 month after surgeryTo define the variability of smoking cessation practices in all patients using the nicotine replacement usage questionnaire
Integration of intervention0 days from recruitment, 1 day or surgeryIntegration of the intervention into the clinical pathway by time from decision to operate from study recruitment
Barriers to recruitment0 days from recruitmentDescriptive reasons for non-participation from screening logs
Smoking cessation in the usual care group1 day of surgery, 1 month after surgeryTo assess the proportion of patients in an observation only usual care group who have quit smoking
Smoking cessation in the intervention group1 day of surgery, 1 month after surgeryTo assess the proportion of patients who receive the intervention who have quit smoking
Qualitative interview1 month after surgeryTo understand patients' experience of and engagement with the intervention, and any unintended consequences To establish whether the intervention is acceptable to thoracic surgery patients and staff, and investigate recommendations for optimisation in intervention delivery
Fine tune procedures and data capture forms0 days from recruitment, 1 day of surgery, 1 month after surgeryTo pilot data capture forms aiming for over 90% completion of important perioperative data for each patient

Contacts

Primary ContactAmy Kerr
amy.kerr@heartofengland.nhs.uk01214241895
Backup ContactSalma Kadiri
salma.kadiri@heartofengland.nhs.uk01214241396

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026